Effect of natural from Tahini oil product on corona
Early Phase 1
- Conditions
- COVID-19.COVID-19U07.1
- Registration Number
- IRCT20140407017169N2
- Lead Sponsor
- Social Development and Health Promotion Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients referred to a specialist center diagnosed by a suspected infectious disease specialist in Corona
Have at least three symptoms of fever / chills, clear chest or voice / shortness of breath, cough / sore throat, general weakness / muscle pain, and have a positive CRP blood test and leukopenia.
Exclusion Criteria
. Pregnant and lactating mothers
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fever. Timepoint: At the beginning of the study (before the start of the intervention) and 7 and 14 days after the start of intervention. Method of measurement: check list.;Chills. Timepoint: At the beginning of the study (before the start of the intervention) and 7 and 14 days after the start of intervention. Method of measurement: check list.;Respiratory rate. Timepoint: At the beginning of the study (before the start of the intervention) and 7 and 14 days after the start of intervention. Method of measurement: check list.;Inpatient period. Timepoint: At the beginning of the study (before the intervention) and 7 and 14 days after the intervention. Method of measurement: check list.;Death of patients. Timepoint: At the beginning of the study (before the intervention) and 7 and 14 days after the intervention. Method of measurement: check list.
- Secondary Outcome Measures
Name Time Method